PFE · After hours
$28.43
+0.94% today·exchange $28.42
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Could a New Vaccine Formula XFG Give Pfizer (PFE) and BioNTech (BNTX) a Post-Pandemic Revenue Boost?
Insider Monkey · just now
Can Eli Lilly Stock Catch Up To Rivals It Outgrows?
Trefis · 2h ago
Can Recent Traction With Key Drugs and Pipeline Progress Boost BMY?
Zacks · 5h ago
AI-Driven Innovation Reshapes Vaccine Adjuvant Discovery as Investment Surges Across Public and Private Sectors
GlobeNewswire · 6h ago
Pfizer or AbbVie: Which Big Pharma Stock Is the Better Pick?
Zacks · 6h ago
Beyond Imbruvica: Can AbbVie Rebuild Its Oncology Portfolio?
Zacks · 7h ago
Headlines from Yahoo Finance. Not investment advice.